A
Apogee Therapeutics D
D
APGE
90.900
USD
6.77
(8.05%)
مغلق
حجم التداول
97,245
الربح لكل سهم
-5
العائد الربحي
-
P/E
-21
حجم السوق
6,852,894,188
العنوان: Apogee Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for thetreatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies bytargeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.
